Status:
ENROLLING_BY_INVITATION
The Efficacy and Adverse Reactions of Neotetracycline in the Treatment of GNB Infections
Lead Sponsor:
The First Affiliated Hospital with Nanjing Medical University
Conditions:
Clinical Efficacy and Safety
Eligibility:
All Genders
18+ years
Brief Summary
A multicenter, retrospective, real-world stduy . Subjects with composite criteria were teated with eravacycline ,and 100 cases ,Tigecycline and 300 cases were to be enrolled.
Detailed Description
The study is a multicenter, retrospective, real-world study, through retrospective collection of cases of gram-negative bacterial infections in the First Affiliated Hospital of Nanjing Medical Univers...
Eligibility Criteria
Inclusion
- Bacteriological results show drug-resistant Gram-negative bacteria Use of new tetracycline drugs for ≥72 hours Age ≥18 years
Exclusion
- Advanced tumors Severe immunodeficiency or mental illness Severe liver and kidney dysfunction Pregnant or breastfeeding women
Key Trial Info
Start Date :
March 1 2024
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
July 30 2026
Estimated Enrollment :
300 Patients enrolled
Trial Details
Trial ID
NCT06990126
Start Date
March 1 2024
End Date
July 30 2026
Last Update
January 6 2026
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
The First Affiliated Hospital of Nanjing Medical University
Nanjing, Jiangsu, China